Detrol and Avastin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Detrol (tolterodine tartrate) and Avastin (bevacizumab). Common drug interactions include malignant neoplasm progression among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Detrol and Avastin. It is created by eHealthMe based on reports of 46 people who take the same drugs from the FDA, and is updated regularly.

What is Detrol?

Detrol has active ingredients of tolterodine tartrate. It is often used in urge incontinence. eHealthMe is studying from 28,669 Detrol users. Check the latest studies of Detrol.

What is Avastin?

Avastin has active ingredients of bevacizumab. It is often used in high blood cholesterol. eHealthMe is studying from 76,365 Avastin users. Check the latest studies of Avastin.



On Jul, 30, 2026

46 people who take Detrol and Avastin together, and have interactions are studied.

Detrol and Avastin drug interactions.

What are the common drug interactions of Detrol and Avastin, by gender? *:

female:

  1. Malignant neoplasm progression (cancer tumour came back)
  2. Anaemia (lack of blood)
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Ankle fracture
  5. Anxiety
  6. Asthenia (weakness)
  7. Atelectasis (partial or complete collapse of the lung)
  8. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  9. Blood creatinine increased
  10. Bone disorder

male:

  1. Death
  2. Erythema (redness of the skin)
  3. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  4. Asthenia (weakness)
  5. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  6. Azotaemia (excess of urea or other nitrogenous compounds in the blood)
  7. Blood creatinine increased
  8. Blood urea increased
  9. Bone disorder
  10. Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)

What are the common drug interactions of Detrol and Avastin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Abasia (inability to walk)
  2. Abdominal pain
  3. Alopecia (absence of hair from areas of the body)
  4. Asthenia (weakness)
  5. Balance disorder
  6. Blindness
  7. Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
  8. Constipation
  9. Fall
  10. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)

50-59:

  1. Death
  2. Abscess (pus)
  3. Anaemia (lack of blood)
  4. Anxiety
  5. Arteriosclerosis (thickening and hardening of arteries)
  6. Arthralgia (joint pain)
  7. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  8. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  9. Azotaemia (excess of urea or other nitrogenous compounds in the blood)
  10. Blood creatinine increased

60+:

  1. Malignant neoplasm progression (cancer tumour came back)
  2. Herpes zoster
  3. Bone disorder
  4. Breast cancer
  5. Breast cancer metastatic
  6. Cervix haemorrhage uterine (bleeding from cervix in birth canal)
  7. Disability
  8. Epicondylitis (tennis elbow)
  9. Hypertension (high blood pressure)
  10. Injury

What are the existing conditions these people have? *

  1. High Blood Pressure: 12 people, 26.09%
  2. Anaemia (lack of blood): 11 people, 23.91%
  3. Hypercalcaemia (elevated calcium (ca+) level in the blood): 10 people, 21.74%
  4. Macular Degeneration (painless eye condition that leads to the gradual loss of central vision): 4 people, 8.70%
  5. Pulmonary Embolism (blockage of the main artery of the lung): 3 people, 6.52%
  6. Nausea (feeling of having an urge to vomit): 3 people, 6.52%
  7. Lung Neoplasm Malignant (cancer tumour of lung): 3 people, 6.52%
  8. Incontinence (lack of moderation or self-control): 3 people, 6.52%
  9. Brain Neoplasm Malignant (brain cancer tumour): 3 people, 6.52%

* Approximation only. Some reports may have incomplete information.

Do you take Detrol and Avastin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Detrol and Avastin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Detrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Avastin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Detrol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Avastin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on tolterodine tartrate and bevacizumab (the active ingredients of Detrol and Avastin, respectively), and Detrol and Avastin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: